Description
Today on MedNet21, we're going to discuss Preventative Cardiology.
At the completion of this activity, the learner should demonstrate understanding of several pivotal lipid lowering treatment guidelines with focus on the 2018 multisociety Guideline on the Management of Blood Cholesterol. The learner should be able to identify key clinical risk factors for atherosclerotic cardiovascular disease as well as “risk enhancing” comorbid medical conditions and/or diagnostic data. The learner should select the appropriate target of lipid lowering therapy (e.g. LDL-C or non-HDL-C) with respect to the patient’s comorbid metabolic conditions.
Dates and Times
End Date: 3/15/2022
Objectives
As a result of this educational activity, webcast participants will be able to: REVIEW the mechanisms of action of the major medication classes utilized in the 2018 multi-society cholesterol guidelines; and UNDERSTAND the influence of the new cardiovascular outcomes trials for ezetimibe and the PCSK9 inhibitors on the new cholesterol guidelines; DEMONSTRATE understanding of key atherosclerotic risk and risk-enhancing factors as well as of recent pivotal lipid lowering treatment guidelines; and SELECT the appropriate target of lipid lowering therapy (e.g. LDL-C or non-HDL-C) with respect to the patient’s comorbid metabolic conditions.
You’ll also learn about the following:
- Cholesterol level goals
- Indications for medical treatment of lipids
- Follow-up of patients started on cholesterol lowering drugs
- Monitoring of cholesterol lowering drugs
- CRP and other inflammatory markers
Webcasts Files
Webcasts Links
| Title | Link |
|---|---|
|
Listen to Audio Only CME Podcasts |
View Link |
Speakers
Accreditation
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.